{"id":343668,"date":"2026-11-11T11:14:57","date_gmt":"2026-11-11T05:44:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=343668"},"modified":"2026-11-11T11:14:57","modified_gmt":"2026-11-11T05:44:57","slug":"automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/","title":{"rendered":"3 Automotive Decorative Parts Maker, Industrial Chemicals Company and Pathology Labs Chain Stocks With a Strong Future Roadmap: SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs: ROE of 10.8% to 20.1% and FY22 to FY26 revenue CAGR of 7.6% to 27.0%. Prices as of 10 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three auto trim, chemical and pathology stocks to watch are SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Their return on equity ranges from 10.8% to 20.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 27.0%. Dr. Lal PathLabs has the highest return on equity at 20.1%, while SJS Enterprises has the fastest revenue growth at 27.0% a year. Prices are based on the 10 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Auto trim, chemical and pathology stocks bring together companies with a visible plan for the years ahead. SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs cover an automotive decorative parts maker, an industrial chemicals company and a pathology labs chain.<\/p>\n<p>This list covers three auto trim, chemical and pathology stocks with complete current figures: SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Every figure comes from the latest reported financials and the 10 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#What_Are_Auto_Trim_Chemical_and_Pathology_Stocks\" title=\"What Are Auto Trim, Chemical and Pathology Stocks?\">What Are Auto Trim, Chemical and Pathology Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Auto_Trim_Chemical_and_Pathology_Stocks_at_a_Glance\" title=\"Auto Trim, Chemical and Pathology Stocks at a Glance\">Auto Trim, Chemical and Pathology Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Why_Do_Auto_Trim_Chemical_and_Pathology_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Auto Trim, Chemical and Pathology Stocks Have a Strong Roadmap in India?\">Why Do Auto Trim, Chemical and Pathology Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Why_SJS_Enterprises_Features_Among_These_Auto_Trim_Chemical_and_Pathology_Stocks\" title=\"Why SJS Enterprises Features Among These Auto Trim, Chemical and Pathology Stocks\">Why SJS Enterprises Features Among These Auto Trim, Chemical and Pathology Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Why_Deepak_Fertilisers_Features_Among_These_Auto_Trim_Chemical_and_Pathology_Stocks\" title=\"Why Deepak Fertilisers Features Among These Auto Trim, Chemical and Pathology Stocks\">Why Deepak Fertilisers Features Among These Auto Trim, Chemical and Pathology Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Why_Dr_Lal_PathLabs_Features_Among_These_Auto_Trim_Chemical_and_Pathology_Stocks\" title=\"Why Dr. Lal PathLabs Features Among These Auto Trim, Chemical and Pathology Stocks\">Why Dr. Lal PathLabs Features Among These Auto Trim, Chemical and Pathology Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#SJS_Enterprises_vs_Deepak_Fertilisers_vs_Dr_Lal_PathLabs_on_Key_Financials\" title=\"SJS Enterprises vs Deepak Fertilisers vs Dr. Lal PathLabs on Key Financials\">SJS Enterprises vs Deepak Fertilisers vs Dr. Lal PathLabs on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Key_Risks_to_Check_Before_Investing_in_Auto_Trim_Chemical_and_Pathology_Stocks\" title=\"Key Risks to Check Before Investing in Auto Trim, Chemical and Pathology Stocks\">Key Risks to Check Before Investing in Auto Trim, Chemical and Pathology Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Final_Thoughts_on_Auto_Trim_Chemical_and_Pathology_Stocks\" title=\"Final Thoughts on Auto Trim, Chemical and Pathology Stocks\">Final Thoughts on Auto Trim, Chemical and Pathology Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#What_are_auto_trim_chemical_and_pathology_stocks\" title=\"What are auto trim, chemical and pathology stocks?\">What are auto trim, chemical and pathology stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Which_auto_trim_chemical_and_pathology_stocks_are_covered_in_this_list\" title=\"Which auto trim, chemical and pathology stocks are covered in this list?\">Which auto trim, chemical and pathology stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Why_do_auto_trim_chemical_and_pathology_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do auto trim, chemical and pathology stocks have a strong future roadmap in India?\">Why do auto trim, chemical and pathology stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#How_has_SJS_Enterprises_performed_financially\" title=\"How has SJS Enterprises performed financially?\">How has SJS Enterprises performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#How_has_Deepak_Fertilisers_performed_financially\" title=\"How has Deepak Fertilisers performed financially?\">How has Deepak Fertilisers performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#How_has_Dr_Lal_PathLabs_performed_financially\" title=\"How has Dr. Lal PathLabs performed financially?\">How has Dr. Lal PathLabs performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#What_risks_should_investors_check_before_buying_auto_trim_chemical_and_pathology_stocks\" title=\"What risks should investors check before buying auto trim, chemical and pathology stocks?\">What risks should investors check before buying auto trim, chemical and pathology stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology-labs-chain-stocks-roadmap-foothill-list\/#Is_this_list_of_auto_trim_chemical_and_pathology_stocks_investment_advice\" title=\"Is this list of auto trim, chemical and pathology stocks investment advice?\">Is this list of auto trim, chemical and pathology stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Auto_Trim_Chemical_and_Pathology_Stocks\"><\/span><strong>What Are Auto Trim, Chemical and Pathology Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Auto trim, chemical and pathology stocks are listed companies that produce decorative badges, trims and surface parts for vehicles, make industrial chemicals and fertilisers, and run a large chain of pathology labs and collection centres. Their earnings depend on vehicle output, chemical and farm demand and test volumes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Auto_Trim_Chemical_and_Pathology_Stocks_at_a_Glance\"><\/span><strong>Auto Trim, Chemical and Pathology Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/sjs\/sjs-enterprises-ltd-share-price-today\">SJS Enterprises<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,052.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,459<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/deepakfert\/deepak-fertilisers-and-petrochemicals-corporation-ltd-share-price-today\">Deepak Fertilisers<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,177.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,354<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.83<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal PathLabs<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,011.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30,949<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">56.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.08<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, all three trade at a P\/E below their industry P\/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing auto trim, chemical and pathology stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in auto trim, chemical and pathology stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Auto_Trim_Chemical_and_Pathology_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Auto Trim, Chemical and Pathology Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Auto trim, chemical and pathology stocks have a strong roadmap in India because buyers preferring premium vehicle finishes, steady demand for industrial chemicals and growing use of preventive health tests keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Auto trim.<\/strong> Buyers prefer premium vehicle finishes.<\/li>\n<li><strong>Industrial chemicals.<\/strong> Mining and industry use these chemicals.<\/li>\n<li><strong>Pathology.<\/strong> Doctors order more tests each year.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_SJS_Enterprises_Features_Among_These_Auto_Trim_Chemical_and_Pathology_Stocks\"><\/span><strong>Why SJS Enterprises Features Among These Auto Trim, Chemical and Pathology Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the auto trim, chemical and pathology stocks on this list, SJS Enterprises makes decorative aesthetic parts such as lenses, badges, decals and appliqu\u00e9s for vehicles, along with products for consumer durables.<\/p>\n<p>The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P\/E of 30.5, below the industry P\/E of 36.9.<\/p>\n<p>Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%. Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.<\/p>\n<p><strong>What to watch:<\/strong> Follow how newly acquired units are integrated and how premium finishes contribute to the mix.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Deepak_Fertilisers_Features_Among_These_Auto_Trim_Chemical_and_Pathology_Stocks\"><\/span><strong>Why Deepak Fertilisers Features Among These Auto Trim, Chemical and Pathology Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the vehicle decor, fertiliser chemical and lab shares on this list, Deepak Fertilisers and Petrochemicals makes industrial chemicals such as ammonium nitrate and nitric acid for mining and industry, along with crop nutrients and fertilisers sold to farmers.<\/p>\n<p>Revenue rose from Rs 7,707 crore in FY22 to Rs 11,609 crore in FY26, a compound annual growth rate of 10.8%. Net profit grew from Rs 468 crore in FY24 to Rs 739 crore in FY26, which works out to a compound annual growth rate of 25.7%.<\/p>\n<p>In the June 2026 quarter, revenue grew 21.6% year on year to Rs 3,262 crore, while net profit rose 101.0% to Rs 490 crore. The company has a return on equity of 10.8%, a debt to equity ratio of 0.83 and a market capitalisation of Rs 14,354 crore. The stock trades at a P\/E of 14.6, below the industry P\/E of 33.2.<\/p>\n<p><strong>Roadmap:<\/strong> The company is expanding its chemical capacity for mining and industrial customers, which supports higher-value sales. Growing mining and infrastructure activity increases demand for its products.<\/p>\n<p><strong>What to watch:<\/strong> Follow mining demand, gas costs and progress on new chemical plants.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Dr_Lal_PathLabs_Features_Among_These_Auto_Trim_Chemical_and_Pathology_Stocks\"><\/span><strong>Why Dr. Lal PathLabs Features Among These Auto Trim, Chemical and Pathology Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Dr. Lal PathLabs is one of India&#8217;s best-known diagnostics companies, operating a national reference laboratory with a hub-and-spoke network of labs, patient service centres and collection points.<\/p>\n<p>In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%.<\/p>\n<p>Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P\/E of 56.6, below the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> Its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.<\/p>\n<p><strong>What to watch:<\/strong> Follow test volumes per patient and the balance between routine and specialised tests.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SJS_Enterprises_vs_Deepak_Fertilisers_vs_Dr_Lal_PathLabs_on_Key_Financials\"><\/span><strong>SJS Enterprises vs Deepak Fertilisers vs Dr. Lal PathLabs on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three auto trim, chemical and pathology stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">SJS Enterprises<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">374<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">973<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">172<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Deepak Fertilisers<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,707<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,609<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">739<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dr. Lal PathLabs<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,140<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,864<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">510<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.8%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Dr. Lal PathLabs posts the highest return on equity in this group at 20.1%. Deepak Fertilisers has the largest FY26 revenue at Rs 11,609 crore, and SJS Enterprises shows the fastest revenue growth with a 27.0% compound annual rate. A useful habit with auto trim, chemical and pathology stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several decorative part, nitric acid and diagnostics stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">SJS Enterprises<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">212<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">266<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Deepak Fertilisers<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,683<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,262<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dr. Lal PathLabs<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">698<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">830<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.9%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Auto_Trim_Chemical_and_Pathology_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Auto Trim, Chemical and Pathology Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these auto trim, chemical and pathology stocks, the main points are: Long-term vehicle decor, fertiliser chemical and lab shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Production cycles.<\/strong> Vehicle output can vary with demand.<\/li>\n<li><strong>Raw material and energy costs.<\/strong> Input prices can move margins in chemicals.<\/li>\n<li><strong>Test volumes.<\/strong> Footfall and test mix can vary with seasons.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter auto trim, chemical and pathology stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Auto_Trim_Chemical_and_Pathology_Stocks\"><\/span><strong>Final Thoughts on Auto Trim, Chemical and Pathology Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Auto trim, chemical and pathology stocks suit investors who prefer to study business strength before price moves. SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs each have a clear plan to grow. Based on the 10 November 2026 close, SJS Enterprises trades at Rs 2,052.8, Deepak Fertilisers at Rs 1,177.3 and Dr. Lal PathLabs at Rs 2,011.5. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these auto trim, chemical and pathology stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track auto trim, chemical and pathology stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_auto_trim_chemical_and_pathology_stocks\"><\/span><strong>What are auto trim, chemical and pathology stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Auto trim, chemical and pathology stocks are listed companies that produce decorative badges, trims and surface parts for vehicles, make industrial chemicals and fertilisers, and run a large chain of pathology labs and collection centres. Their earnings depend on vehicle output, chemical and farm demand and test volumes. This list looks at three of them, SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_auto_trim_chemical_and_pathology_stocks_are_covered_in_this_list\"><\/span><strong>Which auto trim, chemical and pathology stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Based on the 10 November 2026 close, SJS Enterprises traded at Rs 2,052.8, Deepak Fertilisers at Rs 1,177.3 and Dr. Lal PathLabs at Rs 2,011.5. Their return on equity ranges from 10.8% to 20.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 27.0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_auto_trim_chemical_and_pathology_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do auto trim, chemical and pathology stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Auto trim, chemical and pathology stocks have a strong roadmap in India because buyers preferring premium vehicle finishes, steady demand for industrial chemicals and growing use of preventive health tests keep widening the market for these companies. The main drivers are as follows. Auto trim. Buyers prefer premium vehicle finishes. Industrial chemicals. Mining and industry use these chemicals. Pathology. Doctors order more tests each year. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_SJS_Enterprises_performed_financially\"><\/span><strong>How has SJS Enterprises performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%. Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore. The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P\/E of 30.5, below the industry P\/E of 36.9. Looking ahead, premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Deepak_Fertilisers_performed_financially\"><\/span><strong>How has Deepak Fertilisers performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 7,707 crore in FY22 to Rs 11,609 crore in FY26, a compound annual growth rate of 10.8%. Net profit grew from Rs 468 crore in FY24 to Rs 739 crore in FY26, which works out to a compound annual growth rate of 25.7%. In the June 2026 quarter, revenue grew 21.6% year on year to Rs 3,262 crore, while net profit rose 101.0% to Rs 490 crore. The company has a return on equity of 10.8%, a debt to equity ratio of 0.83 and a market capitalisation of Rs 14,354 crore. The stock trades at a P\/E of 14.6, below the industry P\/E of 33.2. Looking ahead, the company is expanding its chemical capacity for mining and industrial customers, which supports higher-value sales. Growing mining and infrastructure activity increases demand for its products.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Dr_Lal_PathLabs_performed_financially\"><\/span><strong>How has Dr. Lal PathLabs performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P\/E of 56.6, below the industry P\/E of 59.6. Looking ahead, its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_auto_trim_chemical_and_pathology_stocks\"><\/span><strong>What risks should investors check before buying auto trim, chemical and pathology stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying auto trim, chemical and pathology stocks. Production cycles. Vehicle output can vary with demand. Raw material and energy costs. Input prices can move margins in chemicals. Test volumes. Footfall and test mix can vary with seasons. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_auto_trim_chemical_and_pathology_stocks_investment_advice\"><\/span><strong>Is this list of auto trim, chemical and pathology stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are auto trim, chemical and pathology stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Auto trim, chemical and pathology stocks are listed companies that produce decorative badges, trims and surface parts for vehicles, make industrial chemicals and fertilisers, and run a large chain of pathology labs and collection centres. Their earnings depend on vehicle output, chemical and farm demand and test volumes. This list looks at three of them, SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which auto trim, chemical and pathology stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Based on the 10 November 2026 close, SJS Enterprises traded at Rs 2,052.8, Deepak Fertilisers at Rs 1,177.3 and Dr. Lal PathLabs at Rs 2,011.5. Their return on equity ranges from 10.8% to 20.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 27.0%.\"}},{\"@type\":\"Question\",\"name\":\"Why do auto trim, chemical and pathology stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Auto trim, chemical and pathology stocks have a strong roadmap in India because buyers preferring premium vehicle finishes, steady demand for industrial chemicals and growing use of preventive health tests keep widening the market for these companies. The main drivers are as follows. Auto trim. Buyers prefer premium vehicle finishes. Industrial chemicals. Mining and industry use these chemicals. Pathology. Doctors order more tests each year. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has SJS Enterprises performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 374 crore in FY22 to Rs 973 crore in FY26, a compound annual growth rate of 27.0%. Net profit grew from Rs 55.0 crore in FY22 to Rs 172 crore in FY26, which works out to a compound annual growth rate of 32.9%. In the June 2026 quarter, revenue grew 25.3% year on year to Rs 266 crore, while net profit rose 115.0% to Rs 74.4 crore. The company has a return on equity of 19.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,459 crore. The stock trades at a P\/E of 30.5, below the industry P\/E of 36.9. Looking ahead, premium finishes, electric vehicle styling and a rising number of parts per vehicle widen its addressable market. The company has also acquired overseas and domestic businesses, which deepen its product range and customer mix.\"}},{\"@type\":\"Question\",\"name\":\"How has Deepak Fertilisers performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 7,707 crore in FY22 to Rs 11,609 crore in FY26, a compound annual growth rate of 10.8%. Net profit grew from Rs 468 crore in FY24 to Rs 739 crore in FY26, which works out to a compound annual growth rate of 25.7%. In the June 2026 quarter, revenue grew 21.6% year on year to Rs 3,262 crore, while net profit rose 101.0% to Rs 490 crore. The company has a return on equity of 10.8%, a debt to equity ratio of 0.83 and a market capitalisation of Rs 14,354 crore. The stock trades at a P\/E of 14.6, below the industry P\/E of 33.2. Looking ahead, the company is expanding its chemical capacity for mining and industrial customers, which supports higher-value sales. Growing mining and infrastructure activity increases demand for its products.\"}},{\"@type\":\"Question\",\"name\":\"How has Dr. Lal PathLabs performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P\/E of 56.6, below the industry P\/E of 59.6. Looking ahead, its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying auto trim, chemical and pathology stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying auto trim, chemical and pathology stocks. Production cycles. Vehicle output can vary with demand. Raw material and energy costs. Input prices can move margins in chemicals. Test volumes. Footfall and test mix can vary with seasons. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of auto trim, chemical and pathology stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Auto Trim, Chemical and Pathology Stocks with a strong future roadmap: SJS Enterprises, Deepak Fertilisers and Dr. Lal PathLabs. Compare price, valuation, return on equity and revenue growth as of 10 November 2026.<\/p>\n","protected":false},"author":35,"featured_media":343667,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[22137,3803,22138,22140,7470,8584,22139,22141,5472,16684],"class_list":["post-343668","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-auto-trim","tag-best-stocks","tag-chemical-and-pathology-stocks","tag-decorative-part","tag-deepak-fertilisers","tag-dr-lal-pathlabs-2","tag-fertiliser-chemical-and-lab-shares","tag-nitric-acid-and-diagnostics-stocks","tag-sjs-enterprises","tag-vehicle-decor"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["343667"],"rank_math_title":["Auto Trim, Industrial Chemical and Pathology Stocks"],"rank_math_description":["Compare 3 auto trim, chemical and pathology stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 10 Nov 2026."],"rank_math_focus_keyword":["auto trim, chemical and pathology stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-automotive-decorative-parts-maker-industrial-chemicals-company-and-pathology.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=343668"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343668\/revisions"}],"predecessor-version":[{"id":343669,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343668\/revisions\/343669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/343667"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=343668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=343668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=343668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}